Valuation: Sinotherapeutics Inc.

Market Cap 443.62Cr 66Cr 58Cr 55Cr 50Cr 93Cr 6.33TCr 94Cr 655.39Cr 253.85Cr 3.24TCr 248.12Cr 242.76Cr 10TCr P/E 2024
35.9x
P/E 2025 88.2x
Enterprise Value 368.97Cr 55Cr 48Cr 46Cr 42Cr 78Cr 5.27TCr 78Cr 545.12Cr 211.13Cr 2.69TCr 206.37Cr 201.91Cr 8.65TCr EV / Sales 2024
7.4x
EV / Sales 2025 8.08x
Free-Float
24.34%
Yield 2024
0.62%
Yield 2025 0.36%
1 day-3.61%
1 week+6.81%
Current month+7.74%
1 month-0.40%
3 months+31.03%
6 months+6.70%
Current year+1.86%
1 week 9.26
Extreme 9.26
10.49
1 month 8.43
Extreme 8.43
10.49
Current year 7.02
Extreme 7.02
11.33
1 year 7.02
Extreme 7.02
11.46
3 years 6.3
Extreme 6.3
14
5 years 6.3
Extreme 6.3
28
10 years 6.3
Extreme 6.3
28
Manager TitleAgeSince
Chief Executive Officer 53 06/04/2023
Director of Finance/CFO 57 30/04/2025
Investor Relations Contact 44 31/05/2023
Director TitleAgeSince
Chairman 53 18/08/2020
Director/Board Member 58 01/08/2012
Director/Board Member 44 01/09/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.61%+6.81%-8.09%-13.10% 66Cr
+0.12%+0.81%+13.81%+64.78% 4.64TCr
+1.09%+0.36%+39.50%+107.67% 3.73TCr
+2.00%+3.78%+18.12%+99.54% 1.25TCr
+0.05%+0.37%-7.29%+18.68% 1.18TCr
0.00%0.00%+18.72%+139.63% 897.09Cr
-1.34%-2.73%+27.67%+37.52% 709.04Cr
-2.07%-2.75%+17.20%+202.97% 700.76Cr
+1.43%+2.22%+43.10%-14.21% 729.19Cr
-2.45%-0.59%-51.49%+4.53% 498.93Cr
Average -0.48%+0.83%+11.13%+64.80% 1.44TCr
Weighted average by Cap. +0.30%+0.57%+19.38%+78.73%

Financials

2024 2025
Net sales 51Cr 7.62Cr 6.69Cr 6.32Cr 5.76Cr 11Cr 730.48Cr 11Cr 76Cr 29Cr 373.19Cr 29Cr 28Cr 1.2TCr 45Cr 6.65Cr 5.84Cr 5.51Cr 5.02Cr 9.41Cr 637.61Cr 9.47Cr 66Cr 26Cr 325.74Cr 25Cr 24Cr 1.05TCr
Net income 13Cr 1.9Cr 1.67Cr 1.58Cr 1.44Cr 2.69Cr 182.33Cr 2.71Cr 19Cr 7.31Cr 93Cr 7.14Cr 6.99Cr 299.37Cr 4.75Cr 70.73L 62.07L 58.62L 53.42L 1Cr 68Cr 1.01Cr 7.02Cr 2.72Cr 35Cr 2.66Cr 2.6Cr 111.31Cr
Net Debt -73Cr -11Cr -9.59Cr -9.06Cr -8.25Cr -15Cr -1.05TCr -16Cr -108.37Cr -42Cr -535.05Cr -41Cr -40Cr -1.72TCr -75Cr -11Cr -9.76Cr -9.22Cr -8.4Cr -16Cr -1.07TCr -16Cr -110.28Cr -43Cr -544.47Cr -42Cr -41Cr -1.75TCr
Logo Sinotherapeutics Inc.
Sinotherapeutics Inc is a China-based company mainly engaged in the research and development, product registration, production and sales of generic drugs, as well as contract research organization/contract manufacture organization (CRO/CMO) services. The Company's main products include posaconazole enteric-coated tablets, mesalazine enteric-coated tablets, ursodeoxycholic acid capsules and others. The Company's products cover multiple fields including antifungal, psychiatric, diabetes, cancer, digestive, hypertension, nephrology, and analgesia. The Company's CRO/CMO services are primarily formulation CRO/CMO services, providing pharmaceutical companies and research institutions with specialized formulation development services during drug development and commercial manufacturing services after drug approval through contracts. The Company mainly conducts its business in the domestic and overseas markets.
Employees
319
Date Price Change Volume
24/26/24 CN¥9.880 -3.61% 92,97,134
23/26/23 CN¥10.25 +2.40% 89,15,571
22/26/22 CN¥10.01 +0.50% 88,70,059
21/26/21 CN¥9.960 +7.68% 1,03,69,551
18/26/18 CN¥9.250 +0.76% 70,37,465
  1. Stock Market
  2. Stocks
  3. 688247 Stock